Georgina Long
BSc(Med), MBBS, PhD, FRACP
Professor and Chair, Melanoma Institute Australia
👥Biography 个人简介
Georgina Long is among the world's most prominent melanoma investigators, leading trials that established nivolumab plus ipilimumab and relatlimab plus nivolumab as new standards for advanced melanoma. She led global registration trials for the anti-LAG3 combination and has championed neoadjuvant IO for resectable stage III melanoma. Her work has changed the trajectory of melanoma outcomes globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Georgina Long 的研究动态
Follow Georgina Long's research updates
留下邮箱，当我们发布与 Georgina Long（University of Sydney / Melanoma Institute Australia）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment